Cornerstone Wealth Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.2M Buy
35,448
+693
+2% +$247K 0.78% 29
2025
Q4
$11.4M Buy
34,755
+2,365
+7% +$750K 0.78% 33
2025
Q3
$9.14M Buy
32,390
+683
+2% +$198K 0.62% 41
2025
Q2
$8.85M Buy
31,707
+12,816
+68% +$3.63M 0.66% 43
2025
Q1
$5.89M Buy
18,891
+5,584
+42% +$1.65M 0.49% 61
2024
Q4
$3.47M Buy
13,307
+363
+3% +$108K 0.28% 88
2024
Q3
$4.17M Buy
12,944
+130
+1% +$42.5K 0.34% 82
2024
Q2
$4M Buy
12,814
+321
+3% +$94.3K 0.36% 72
2024
Q1
$3.55M Buy
12,493
+11,214
+877% +$3.28M 0.33% 77
2023
Q4
$368K Buy
1,279
+146
+13% +$39.8K 0.05% 113
2023
Q3
$304K Buy
+1,133
New +$283K 0.05% 122
2023
Q2
Sell
-886
Closed -$214K 146
2023
Q1
$214K Buy
+886
New +$217K 0.04% 137

Other funds holding AMGN

Cornerstone Wealth Group's AMGN Position: Q1 2026 in Review

Cornerstone Wealth Group increased its Amgen (AMGN) stake by 2% in Q1 2026, buying an estimated $247K and bringing the position to 35,448 shares worth $12.2M. The position accounts for 0.78% of the portfolio, ranked #29.

Cornerstone Wealth Group first reported a position in AMGN in Q1 2023 and has held it in 12 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Cornerstone Wealth Group held 35,448 shares of Amgen worth $12.2M as of Q1 2026.
  • Cornerstone Wealth Group bought 693 Amgen shares in Q1 2026, an estimated $247K.
  • Amgen made up 0.78% of Cornerstone Wealth Group's portfolio in Q1 2026, its #29 holding.
  • Cornerstone Wealth Group first reported a position in Amgen in Q1 2023 and has held it in 12 quarters since.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Cornerstone Wealth Group's 13F filing for Q1 2026, filed 22 Apr 2026.